Several brokerages have updated their recommendations and price targets on shares of Novartis (NYSE: NVS) in the last few weeks: 9/21/2026 – Novartis had its “sell” rating reaffirmed by The Goldman Sachs Group, Inc.. 9/17/2026 – Novartis had its “neutral” rating reaffirmed by UBS Group AG. 9/17/2026 – Novartis had its “neutral” rating reaffirmed by […]

A number of research firms have changed their ratings and price targets for Western Alliance Bancorporation (NYSE: WAL): 9/29/2026 – Western Alliance Bancorporation had its price target lowered by Wells Fargo & Company from $90.00 to $84.00. They now have an “equal weight” rating on the stock. 9/22/2026 – Western Alliance Bancorporation had its price […]

A number of research firms have changed their ratings and price targets for Krystal Biotech (NASDAQ: KRYS): 9/24/2026 – Krystal Biotech was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”. 9/24/2026 – Krystal Biotech is now covered by The Goldman Sachs Group, Inc.. They set a “buy” rating and a $441.00 price target […]

A number of research firms have changed their ratings and price targets for Dyne Therapeutics (NASDAQ: DYN): 9/30/2026 – Dyne Therapeutics had its “buy” rating reaffirmed by Cantor Fitzgerald. 9/30/2026 – Dyne Therapeutics had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $50.00 price target on the stock. 9/30/2026 – […]

A number of research firms have changed their ratings and price targets for Almonty Industries (NASDAQ: ALM): 9/25/2026 – Almonty Industries was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”. 9/25/2026 – Almonty Industries is now covered by Stifel Nicolaus. They set a “buy” rating and a $25.00 price target on the stock. […]

A number of research firms have changed their ratings and price targets for Upexi (NASDAQ: UPXI): 9/20/2026 – Upexi was downgraded by Wall Street Zen from “hold” to “sell”. 9/18/2026 – Upexi had its “overweight” rating reaffirmed by Cantor Fitzgerald. They now have a $2.00 price target on the stock. 9/12/2026 – Upexi was upgraded […]

Several brokerages have updated their recommendations and price targets on shares of Casey’s General Stores (NASDAQ: CASY) in the last few weeks: 9/16/2026 – Casey’s General Stores had its “outperform” rating reaffirmed by William Blair. 9/12/2026 – Casey’s General Stores was downgraded by Wall Street Zen from “buy” to “hold”. 9/11/2026 – Casey’s General Stores […]

Twist Bioscience (NASDAQ: TWST) recently received a number of ratings updates from brokerages and research firms: 9/21/2026 – Twist Bioscience had its “sell (d-)” rating reaffirmed by Weiss Ratings. 9/18/2026 – Twist Bioscience had its “sell” rating reaffirmed by BWS Financial. They now have a $45.00 price target on the stock. 9/17/2026 – Twist Bioscience […]

Climb Bio (NASDAQ: CLYM) has recently received a number of price target changes and ratings updates: 9/16/2026 – Climb Bio was upgraded by Mizuho to “strong-buy”. 9/8/2026 – Climb Bio had its price target raised by Oppenheimer Holdings, Inc. from $18.00 to $25.00. They now have an “outperform” rating on the stock. 9/8/2026 – Climb […]